Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George Coukos
Centre hospitalier universitaire vaudois, Lausanne
Study Chair - Susana- Banerjee
Royal Marsden Hospital - UK
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Assistance Publique - Hopitaux de Paris - Hopital Europeen Georges Pompidou
Paris, France
- Centre Hospitalier Privé Saint-Grégoire
Saint-Grégoire, France
- Academisch Medisch Centrum - Universiteit Van Amsterdam
Amsterdam, Netherlands
- Leiden University Medical Centre
Leiden, Netherlands
- Radboudumc - Radboud University Medical Center Nijmegen
Nijmegen, Netherlands
- Institut Catala D'Oncologia - Ico Badalona - Hospital Germans Trias I Pujol (institut Catala D'Oncologia)
Badalona, Spain
- Hospital Universitario San Carlos
Madrid, Spain
- Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
- Centre Hospitalier Universitaire Vaudois - Lausanne
Lausanne, Switzerland
- Guy'S and St Thomas' Nhs - Guy S and St Thomas' Nhs - Guy'S Hospital
London, United Kingdom
- Royal Marsden Hospital - Chelsea, London
London, United Kingdom
- Royal Marsden Hospital - Sutton, Surrey
Sutton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2016
- Primary completion
- 30 Jun 2021
- Completion
- 31 Mar 2022
- Last update posted
- 14 Mar 2023
- Registered enrollment
- 122
- Registry id
- NCT02659384
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.